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Recently a second, alternate pathway of complement activation has been described 
which bypasses C1, C2, and C4 and enters the classical pathway with the reaction of 
C3 (1-3).  1 One of the proteins of this pathway, a heat-labile fl-globulin, is cleaved on 
triggering of the alternate pathway in serum; since the major cleavage product of this 
protein activates C3, the precursor has been termed the C3 proactivator (C3PA) (1). 2 
C3PA is antigenically related to glycine-rich/~-globulin  (GBG) isolated by 13oenisch 
and Alper (4) and fl~-glycoprotein  type II isolated by Haupt and Heide (1, 5). C3PA 
is also felt to be identical with factor B of the properdin system (6, 7), since it par- 
ticipates in the bactericidal activity of serum (1, 8) and in the lysis of erythrccytes 
from patients with paroxysmal nocturnal hemoglobinuria (9). 
C3PA was originally identified as the protein in normal serum which combines with 
a protein isolated from cobra (Naja naja) venom to form a  complex capable of ac- 
tivating C3  and initiating complement action at this step  (10-17). Recently Alper 
et al. (18)  and Hunsicker et al. (19),  on the basis of studies with isolated GBG and 
fi~-glycoprotein  II, have independently challenged the concept that  C3PA forms  a 
complex with cobra venom factor (CoF), and that it is this complex which acts on C3. 
These reports necessitated a  reinvestigation of  the  role of  C3PA and CoF 
in the  formation of  the  principle which  is  capable  of  initiating complement 
action at  the  C3  step.  The  results of  these  studies  clearly demonstrate the 
occurrence of two  distinct modes of interaction of C3PA with  CoF. 
Materials and Methods 
C3PA was isolated from human serum as described by GStze and Mfiller-Eberhard (1). 
CoF was obtained by the method described by Mttller-Eberhard and FjellstrSm (16), except 
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that G-200 was used in place of G-100 Sephadex. C3 and other complement components were 
isolated by published methods (20).  Preparations of C3PA and CoF were trace labeled with 
125iodine and  I31iodine by the chloramine-T method (21) without loss of functional activity. 
Rabbits  were immunized  with isolated  C3PA to prepare  antisera  to  the protein.  Anti-~2- 
glycoprotein type II was purchased from Behringwerke AG., Marburg,  W.  Germany, while 
antiserum to GBG was kindly provided by Dr. C. A. Alper. Serum was depleted of C3PA by 
absorption  with  insolubilized  antiserum  to  C3PA  (1);  the author  wishes  to  thank  Dr.  O. 
G~Stze for his gift of serum depleted of C3PA. 
7 -31~/~ linear sucrose gradients in 0.05 M Tris-HCI, pH 7.5, containing 0.0002 M Ca  ++ and 
0.001  M  Mg  ++, were centrifuged at 39,000  rpm for 16 h in an SW-50L rotor in a Beckman 
1,2-50  ultracentrifuge  (Beckman  Instruments,  Inc.,  Fullerton,  Calif.).  Markers  were  Clq 
(llS)  and  human  serum albumin  (4.5S),  both of which were localized by immunochemical 
analysis,  equine cytochrome c  (1.7S),  which was identified spectrophotometrically, and  the 
meniscus.  Polyacrylamide gel electrophoresis was performed in  6% gels in Tris-HC1  buffer, 
pH 8.7  (22). 
C3 hemolytic activity was determined by molecular titrations utilizing EAC 1, 4, 2, C5, and 
an EDTA serum reagent deficient in C3 and C5 (23). C3 inactivating activity was quantitated 
by incubating gradient fractions or mixtures of C3PA and Col: with 5 #g of C3 for 30 rain 
at 37°C in a total volume of 50-100/~l. The mixtures were then diluted for hemolytic assay 
of residual  C3. 
C3PA was measured as follows. Gradient fractions were added to 0.2 ml of a 1 : 15 dilution 
of serum previously heated at 50°C for 20 rain.  Serum heated in this manner is deficient in 
C3PA (9). Subsequently, 20/~g of inulin was added and the mixtures incubated for 30 min at 
30°C. Then the serum was diluted and residual  C3 quautitated by effective molecule titration. 
A value of 200 ~g/ml was used as the serum concentration  of C3PA for the purpose  of 
determining molar ratios.  Molecular weights of 80,000, 150,000, and  185,000 were used  for 
C3PA, Col", and C3, respectively. 
RESULTS 
Characlerization  of C3PA  and  CoF Preparations.--Several  approaches  were 
employed  to  determine  molecular  homogeneity  and  functional  activity of  the 
C3PA  preparations  employed  in  these  studies.  C3  proactivator  preparations 
gave  a  single  stained  band  after  electrophoresis  in  6c~  polyacrylamide  gels. 
Similarly,  radiolabeled  C3PA  preparations  gave  one  discrete  peak  of  radio- 
activity during  electrophoresis  in polyacrylamide  gels or during  ultracentrifu- 
gation  in  sucrose  density  gradients.  Rabbits  immunized  with  C3PA  produced 
antibody  which gave a  single line on Ouchterlonv anatvsis  with human  serum. 
In order to determine if the preparations  contained  additional proteins  masked 
by the position of the C3PA band  in polyacrylamide gels, 50 ~1 of antiserum  to 
C3  proactivator  was  added  to  5  #g  of  I~2:'I]C3PA  before  electrophoresis  in 
l)olyacrylamide  gels.  Subsequently  the  gels  were  sectioned  and  radioactivity 
present  in  the segments was determined.  As shown  in  Fig.  1,  previous incuba- 
tion  of  [12'~I]C3PA  with  anti-C3PA  prevented  all  radioactivity  from  entering 
the  gel.  identical  results  were  obtained  from  incubation  of  I~2'~I]C3PA  with 
either 50 #l of antiserum  to fl2-glycoprotein type II, or of antiserum  to glycine- 
rich  fl-glycoprotein.  While  a  given  antiserum  might  contain  antibody  to 
proteins possibly  contaminating  the  C3PA preparations,  it is unlikely  that  all 
of the antisera employed would contain antibody to the same contaminant. NEIL  R.  COOPER  453 
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FIG. 1.  Polyacrylamide  gel electrophoresis  of 5 #g of [12~I]C3PA previously incubated with 
various antisera. After electrophoresis the gels were sectioned and the amount of radioactivity 
present in the segments determined. 
Three tests were employed to determine the functional  activity of isolated 
preparations of  C3PA.  First,  unlabeled  and  radiolabeled  C3PA  preparations 
were examined for their ability to be cleaved by incubation  with  C3PA  con- 
vertase  (C3PAse)  and  activated  hydrazine-sensitive  factor  (HSFa)  (24). 
Secondly,  C3PA  preparations  were  tested  for their  ability  to  restore  the  C3 
cleaving activity in heated serum (50°C,  20 min). In this test inulin  was used 
as  the  triggering  substance.  Thirdly,  C3PA  preparations  were  analyzed  for 
their  capacity  to  cleave  C3  upon  addition  of an  equimolar  concentration  of 
CoF and factor D  (see below). The preparations used in this study were found 
to be fully active in all three tests. 
CoF preparations were also examined for molecular homogeneity. Only one 
stained  band,  or, in  the  case of radiolabeled preparations, only a  single sym- 
metrical peak of radioactivity, was evident after electrophoresis in polyacryla- 
mide gels. Antisera  reactive only with CoF were produced in  rabbits. Incuba- 
tion of [lalI]CoF preparations with  the TG fraction of anti-CoF  serum before 
electrophoresis in  6% polyacrylamide gels completely prevented  the  entry of 
radioactivity into the running gel. CoF preparations had the functional activity 
characteristic of this protein, i.e.,  C3 cleaving activity appeared upon addition 
of CoF to serum. 
The  above  studies  indicate  that  contaminating  proteins  represent  a  very 
minor proportion, less than 5 ~, of the total protein present in the C3PA and 
CoF  preparations.  The  preparations  have  the  functional  activities  charac- 
teristic for these proteins. 
Complexing of CoF wilh C3PA  in Serum.--C3PA  and  CoF  were  added  to 
normal human serum in  12'~I- and raq-radiolabeled forms, respectively. 5 #g of 
[r251]C3PA was added  to the approximately- 8/zg of C3PA present in 40/~I of 
serum. In a series of 15 experiments, CoF was added to the serum mixtures to 
achieve various molar ratios between  CoF and  C3PA.  After 30 rain  at 37°C, 
marker  substances  were  added  and  the  mixtures  were  analyzed  by  sucrose 
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was employed or when C3PA was in excess, the sedimentation rate of [~aq]CoF 
was increased from approximately 7S,  the velocity in the absence of serum, to 
8  9S  (Fig.  2).  The sedimentation rate of C3PA  was also increased from 5-6S 
to 8-9S; furthermore, its position correlated with that of CoF (Fig. 2). At less 
than  equimolar  CoF:C3PA  ratios,  C3PA  appeared  as  a  5-6S  peak,  with  a 
heavier shoulder coinciding in position with the 8--9S CoF peak. Essentially the 
converse  was  seen  when  adding  CoF  in  molar  excess  (Fig.  2):  C3PA  was 
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Fro. 2.  Sucrose gradient ultracentrifugation of serum to which a trace of [125I]C3PA  and 
varying amounts of [x3JI]CoF have  been added.  Radioactivity  and C3  inactivating activity 
of the gradient fractions was determined. 
entirely in the 8-9S region along with some of the CoF; the bulk of CoF, how- 
ever, sedimented with an S rate of 7.3S.  Identical  results were obtained from 
Ouchterlony analyses of the gradient fractions with antiserum to C3PA. Fig. 3 
demonstrates such a study with a partially purified C3PA preparation. 
Similar studies were performed with serum previously depleted of C3PA by 
absorption with insolubilized anti-C3PA (Fig. 4). In five experiments with two 
preparations of C3PA-depleted  serum,  CoF added  to  the  depleted  serum re- 
mained in 7S position. A shift of CoF to 8-9S was readily produced by addition 
of isolated C3PA to the mixture of CoF and C3PA depleted serum. 
C3  cleaving activity was  regularly demonstrable  in  the  8-9S  region  of the NEIL  R.  COOPER  455 
normal serum density gradients.  Its distribution  correlated exactly with  that 
of CoF when C3PA was in molar excess over CoF, with the peak of both CoF 
and  C3PA when these proteins were present in equimolar concentrations,  and 
with the C3PA peak when CoF was in molar excess. C3 cleaving activity was 
Fx6. 3.  Sucrose gradient ultracentrifugal analyses of partially purified C3PA (lower panel) 
and C3PA previously incubated with CoF  (upper p~uel). The control panel shows the reac- 
tivity of the gradient fractions with anti-C3PA. The direction of sedimentation is to the left. 
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FIG.  4.  Sucrose gradient ultracentrifugation  of serum previously depleted of C3PA.  In 
the upper panel CoF has been added to the serum. Complex formation is not evident. A com- 
plex is formed by addition of C3PA as well as CoF to the serum (lower panel). 456  C 3  PROACTIVATOR  COMPLEX  IeROM  COBRA  VENOM  PROTEIN 
not  found when adding  CoF to  C3PA-depleted  serum. Results comparable to 
those given above were observed during electrophoretic analyses of ['25I]C3PA- 
(la~IJCoF serum mixtures in polyaerylamide gels. 
Reversible Complexing  of  Isolated  C3PA  with  CoF.--Mixtures  of  isolated 
radiolabeled C3PA and CoF were analyzed bv ultracentrifugation in a series of 
18  experiments  with  a  number  of  C3PA  preparations.  Whenever  C3PA  was 
present in equimolar or less than equimolar ratios with CoF, C3PA sedimented 
as  at 5-6S  peak  with  a  heavier shoulder  coinciding  in  position  with  the  CoF 
peak  (Fig.  5);  the  sedimentation  rate  of  CoF  was  also  slightly  increased. 
Reversible  formation of  a  protein-protein  complex  was  also  demonstrable  in 
polyaerylamide gel  electrophoretic  analyses of C3PA-CoF  mixtures  (1).  Mix- 
tures of isolated ('3PA and CoF possessed C3  cleaving activity. This reaction, 
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FIG.  5.  Sucrose  gradient  ultracentrifugal  analysis  of  an  equimolar  mixture  <->f isolated 
Col: and C3PA  (upper panel)  and the same mixture in the presence of factor D. 
however,  was relatively' inefficient and  C3  cleaving  activity could  not  be  de- 
tected  in  gradient  fractions. 
Requirement for an Additional  Factor for t~I~cienl C3PA-CoF Complexing and 
for  Generation  of  C3  Cleaving Activity.---Although  C3PA  and  CoF  readily 
formed  a  firm  complex  in  serum  which  possessed  C3  inactivating  activity, 
isolated C3PA  and  CoF exhibited  only a  weak reversible complex with ineffi- 
cient C3 cleav[ng activity. These observations led to a search for a serum factor 
which  would  enhance  complex formation  and  C3  cleaving  activity of  C3PA- 
CoF mixtures. A factor with these properties was identified and isolated in par- 
tially  purified  form  by  a  combination  of  BioRex  colunm  chromatography 
(elut[on  peak  22  29  mnaho/cm),  DE-32  cellulose  chromatography  (elution 
peak  2-4  mmho/cm),  and  Pevikon  block  electrophoresis  (slow  c~  to  fast 
mobility). This substance is  termed factor D  because of similarity to a  factor 
termed  "D"  which  has been described  by Hunsicker  et  al.  (19).  Factor  D  is NEIL  R.  COOPER  457 
apparently a trace constituent of serum, since less than 10 #g could be obtained 
per 100 ml of plasma. 
The  enhancing  effect  of factor D  on  the  formation  of a  complex  of  C3PA 
with CoF is shown in Fig. 5. The reaction mixtures contained 10/,g of [~aJI]CoF 
and 5 #g of p2q]C3PA.  C3PA incubated with CoF in the presence of factor D 
sedimented  as a  9S peak;  C3 inactivating  activity also correlated  in distribu- 
tion with this peak. The bulk of CoF also was present in this area of the gradi- 
ent,  although  the peak of [Ia~IJCoF sedimented  at 8S. A  second 3.5-4.5S peak 
of C3PA was often seen  (Fig. 5). 
Very small amounts of factor D  increased the C3 cleaving activity of C3PA- 
CoF mixtures as shown in Table I. Enhanced  C3 cleaving activity of a  1:1:2 
molar  ratio  of C3PA:CoF:C3 was  still  evident  upon  addition  of as  little  as 
30 ng of partially purified factor D. 
DISCUSSION 
An identical distribution  of CoF, C3PA, and C3 cleaving activity was found 
on  sucrose  density  gradient  ultracentrifugation  of  serum  containing  CoF  in 
amounts equimolar to the  total C3PA present  (Fig. 2).  When CoF was added 
to serum in amounts which were less than equimolar to the C3PA content,  all 
of the  CoF sedimented  as an 8-9S peak which correlated with the peak of C3 
inactivating  activity.  Some  of the  C3PA  also  was present  in  this  region,  as 
shown by a  shoulder on the heavy side of the 5-6S  C3PA peak (Fig. 2).  Con- 
versely, C3PA sedimented with an 8-9S peak which correlated with the location 
of C3 cleaving activity when  CoF was added  to serum in a  molar excess over 
the  C3PA present.  Under  these  conditions,  CoF gave a  7S peak  which  had  a 
shoulder on the heavy side which encompassed the C3PA peak.  These studies 
document the formation in serum of a  firm complex of C3PA with CoF which 
possesses C3 cleaving activity. The essential  role of C3PA in formation of this 
complex is shown by the failure of CoF to form a complex by addition to serum 
"FABLE  I 
liffect of Factor D  on the C3 Cleazing Activily ~( C3PA  and CoF 
C3PA*  CoF*  Factor D  E.M. of C3 consumed,+ 
ng 
+  +  None  675 
+  +  30  950 
+  +  60  1,050 
+  +  150  1,200 
+  +  300  1,300 
0  0  300  None 
* 3.2/zg C3PA and 6/zg of CoF incubated with C3 for 30 rain. 
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previously depleted  of  C3PA  by absorption  with  insolubilized antiserum  to 
C3PA (Fig. 4). 
Sucrose density gradient ultracentrifugal analyses of isolated C3PA and CoF 
revealed weak reversible interaction between the two proteins. An additional 
factor present in normal serum was required to induce firm complexing of iso- 
lated C3PA  with  CoF and  to endow this complex with efficient C3  cleaving 
activity.  This  serum protein  is  probably  identical  with  a  substance  termed 
factor D  by Hunsicker et al.  (19) which is required for mixtures of C3PA and 
CoF to manifest C3 cleavage activity. 
The data presented here thus confirm and extend the earlier studies which 
indicated  that  CoF complexed with  C3PA  (1,  16).  Two types of interaction 
were observed. In free solution the two proteins exhibited an affinity for each 
other and formed a reversible complex. In the presence of factor D, they gave 
rise to a firm complex which was able to cleave C3 enzynlatically. This repre- 
sents  another example  of a  functionally relevant protein-protein interaction 
within  the  complement system.  Other examples  are  found in  the  affinity of 
Clq for 3'-globulin (25)  and the formation of complexes of Clq with Clr and 
Cls (26), of C2 with C4 (27), of C5 with C6 and C7  (28), and of C8 with C9 
(29). 
The reason Hunsicker et al.  (19)  and Alper et al.  (18)  failed to observe the 
formation of a  complex of C3PA  with  CoF is not clear. The present studies 
(Fig.  1) clearly indicate that the C3PA used in this study is antigenically re- 
lated to fl2-glycoprotein type II and to GBG which Hunsicker et al.  (19)  and 
Alper et al.  (18)  employed in their respective studies.  The data also indicate 
that the preparations of C3PA employed in the present study were functionally 
active and physicochemically homogeneous. 
The identity and mode of action of factor D  are uncertain. The small size, 
electrophoretic mobility, and elution position from anion and cation exchange 
columns suggest that factor D  might be C3PAse, an enzyme which cleaves and 
activates C3PA in the presence of a C3 fragment called HSFa (24).  CoF is not 
required  for  this  reaction.  The  occasional  finding  of  C3PA  cleavage during 
reaction with CoF and factor D  (Fig. 5) support a common identity of factor D 
and C3PAse. Although C3PAse activity has not been consistently detected in 
factor D  preparations, this does not preclude identity of the two proteins be- 
cause of differences in dose-response requirements. Although the exact role and 
identity of factor D  remain to be elucidated, it is clear that it is an activator of 
C3PA.  In  its  mechanism  of action  factor D  also  resembles  Cls,  which  also 
induces the formation of a firm, metal-dependent, enzymatically active complex 
between two proteins. 
SUMMARY 
The role of C3 proactivator (C3PA) and a factor isolated from cobra venom 
(CoF) in the formation of a principle able to cleave C3 was investigated. The NEIL  R.  COOPER  459 
results  clearly demonstrate  two  modes  of interaction of C3PA  with  CoF.  In 
isolated form, C3PA and CoF were found to form a  reversible protein-protein 
complex in free solution. This complex had some C3  cleaving activity. In  the 
presence  of minute  amounts  of a  partially purified normal  serum  substance, 
factor D, the C3PA-CoF complex was stabilized and its efficiency in cleaving C3 
was greatly increased. Factor D  is thus an activator of C3PA. A  firm complex 
composed  of  C3PA  and  CoF,  and  possessing  C3  cleaving activity,  was  also 
formed by addition of CoF to serum. 
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